Listar Bordeaux Population Health Research Center (BPH) - UMR 1219 por institución "INRIA"
Mostrando ítems 21-36 de 36
-
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
(Journal of Immunology. vol. 208, n° 12, pp. 2663-2674, 2022-06-15)Article de revue -
ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned.
(Joint Bone Spine. vol. 90, n° 5, pp. 105607, 2023-09-01)Article de revue -
Random survival forests with multivariate longitudinal endogenous covariates
(Statistical Methods in Medical Research. vol. 32, n° 12, pp. 2331-2346, 2023-12-01)Article de revueLibre acceso -
Robust and Efficient Optimization Using a Marquardt-Levenberg Algorithm with R Package marqLevAlg
(R Journal. vol. 13, n° 2, pp. 365-379, 2021-12)Article de revueLibre acceso -
SAMBA: a Novel Method for Fast Automatic Model Building in Nonlinear Mixed-Effects Models
(CPT: Pharmacometrics and Systems Pharmacology. vol. 11, n° 2, pp. 161-172, 2022-02)Article de revueLibre acceso -
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
(PLoS ONE. vol. 18, n° 1, pp. e0266985, 2023-04-05)Article de revueLibre acceso -
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
(European Radiology, 2023-07-05)Article de revueLibre acceso -
Public Health surveillance from emergency call center data: visualization dashboard and NLP of call reports: Public Health surveillance from EMCC data
(The International FLAIRS Conference Proceedings, FLAIRS-35 - 35th International Florida Artificial Intelligence Research Society Conference, us, Hutchinson, 2022-05-04)Communication dans un congrès avec actesLibre acceso -
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
(International Journal of Epidemiology. vol. 53, n° 1, 2024-02-01)Article de revueLibre acceso -
Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)): Results from a phase 2, randomized, placebo-controlled trial in children and adults
(Clinical Infectious Diseases, 2023-11-15)Article de revueLibre acceso -
Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study)
(Scientific Reports. vol. 13, n° 1, pp. 16535, 2023-10-02)Article de revueLibre acceso -
Serious Games for Training in Patient Flow Management in Emergency Departments: State of the Art and Perspectives
Communication dans un congrèsLibre acceso -
Safety and Immunogenicity of Hpv Vaccination in Immunocompromised Girls: The Primavera Clinical Trial (Nct 01687192)
Communication dans un congrès -
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
(NPJ vaccines. vol. 8, n° 1, pp. 174, 2023-11-08)Article de revueLibre acceso -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre acceso -
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen
(PLoS Neglected Tropical Diseases. vol. 18, n° 4, pp. e0011500, 2024-04-11)Article de revueLibre acceso